Unpacking Trial Offers and Low Accrual Rates: A Qualitative Analysis of Clinic Visits With Physicians and Patients Potentially Eligible for a Prostate Cancer Clinical Trial We identified 11,554 ...
Adding carboplatin to standard neoadjuvant chemotherapy improves overall survival in TNBC, but the benefit is only ...
A dose-dense weekly schedule of paclitaxel (resulting in a greater frequency of drug delivery) plus carboplatin every 3 weeks or the addition of bevacizumab to paclitaxel and carboplatin administered ...
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial Eligible adults had previously ...
Up to now, patients with inoperable anal cancer, a rare disease, have not had a standard-of-care treatment; palliative care has been the routine for them. Now, results from InterAAct, the first ...
Intravenous paclitaxel and intraperitoneal carboplatin, and intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel may be viable treatment options for patients with ...
The genetic and clinical heterogeneity of breast cancer makes the identification of effective therapies challenging. We designed I-SPY 2, a phase 2, multicenter, adaptively randomized trial to screen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback